论文部分内容阅读
近年来,肝素治疗病毒性肝炎的报告日渐增多,其结论大多数是肯定的。但都是用静脉注射给药的方法,出血的副作用仍多,还需要实验室监护,给肝素临床应用带来一定的困难。为此临床医学家推荐使用皮下注射小剂量肝素疗法,目前,这一疗法已取得较好的效果。为了探索肝素钙和肝素钠皮下注射的疗效和副作用有何不同?木协作组对苏州生化制药厂生产的肝素钙和肝素钠进行了临床试用。现将1982～83年临床资料较完整的232例病毒性肝炎加以分析
In recent years, reports of heparin treatment of viral hepatitis have been increasing, and most of the conclusions are affirmative. But all are given by intravenous injection method, the side effects of bleeding is still more, but also need laboratory care, clinical application of heparin to bring some difficulties. For this reason clinicians recommend the use of subcutaneous low-dose heparin therapy, at present, this therapy has achieved good results. In order to explore the effect of heparin and heparin sodium subcutaneous injection of side effects and what is the difference? Wood collaborative group of Suzhou Biochemical Pharmaceutical Factory produced heparin and heparin sodium clinical trial. Now 1982 ~ 83 clinical data more complete analysis of 232 cases of viral hepatitis